Overview

CIT GAP Funds makes seed-stage equity investments in Virginia-based technology and life science companies with a high potential for achieving rapid growth and generating significant economic return. CIT’s family of funds includes:

GAP I – A vintage 2004 fund fully invested in a broad array of seed-stage technology companies. Portfolio.

Based on the success of GAP I, CIT launched two specialized follow-on funds in 2007.

GAP BioLife – A seed fund investing exclusively in life science companies.
GAP Tech – A seed fund investing in IT and technology companies.

For investment criteria click here.

GAP Fund I Highlights

Global Cell Solutions closed a Series A round on 4/22/08
SquareLoop closed a Series A round on 12/17/07
Tau closed a Series A round on 10/19/07
Verical closed a Series A round on 9/27/07
Plurapage closed a Series A round on 4/13/07
4FrontSecurity was acquired by Symantec on 2/23/07
Visure closed a Series A round on 2/22/07
RollStream closed a Series A round on 7/17/06
Paxfire closed a Series A round on 4/22/05